MedPath
NMPA Approval

Heparolysate Injection

国药准字H20054214

September 28, 2021

国药准字H20054214

Drug Information

肝水解肽注射液

注射剂

5ml:50mg

化学药品

September 28, 2021

Company Information

Applicant Company

长春经济技术开发区海口路572号

Manufacturing Company

长春经济技术开发区海口路572号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

肝水解肽注射液 - NMPA 批准文号 | MedPath